Newsfeeds - Spark Newswire

1 minute read

Amarin Corp Q3 Adj. EPS $0.02 Down From $0.03 YoY, Sales $89.88M Miss $142.04M Estimate

October 27, 7:04 AM

Amarin Corp (NASDAQ:AMRN) reported adjusted quarterly earnings of $0.02 per share. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of

AMRN

18 minute read

Earnings

Earnings Scheduled For October 27, 2022

By Benzinga Insights

October 27, 5:33 AM

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million.

AAPL

1 minute read

SVB Leerink Maintains Market Perform on Amarin Corp, Lowers Price Target to $2

By Benzinga Newsdesk

October 19, 6:35 AM

SVB Leerink analyst Roanna Ruiz maintains Amarin Corp (NASDAQ:AMRN) with a Market Perform and lowers the price target from $3 to $2.

AMRN

2 minute read

Amarin Issues Statement In Response To Sarissa, Says Has Engaged Proactively And Frequently With Sarissa

By Benzinga Newsdesk

October 11, 4:17 PM

Amarin Corporation plc (NASDAQ:AMRN) today issued the following statement in response to Sarissa Capital Management LP ("Sarissa") on behalf of the Amarin Board of Directors: As a Board, we are unified and

AMRN

56 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 22, 2:17 PM

On Thursday, 1076 companies hit new 52-week lows.

$APE

28 minute read

Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

September 1, 12:58 PM

On Thursday, 529 companies set new 52-week lows.

$APE

1 minute read

Amarin Touts Positive Data For Its Heart Disease Drug In Current/Former Smokers

By Vandana Singh

August 29, 7:16 AM

Amarin Corporation plc (NASDAQ:AMRN) announced that new REDUCE-IT data show that Vascepa/Vazkepa (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients…

AMRN

1 minute read

Amarin’s New Vascepa Data Shows Significant Reduction In Heart Attack Subtypes

By Vandana Singh

August 26, 12:08 PM

New data shows that Amarin Corporation plc's (NASDAQ: AMRN) Vascepa/Vazkepa (icosapent ethyl) significantly reduced ST-segment and non-ST elevation myocardial infarction (NSTEMI) and other MI subtypes in patients with cardiovascular disease or diabetes with risk factors.

AMRN

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

August 22, 2:30 PM

AGLE

5 minute read

Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

August 22, 1:02 PM

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares surged 78% to $2.2399 as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.

ADES